This guideline updates the 2017 guideline on clinical indications and drug regimens for PrEP and PEP in Canada and contains 31 recommendations and 10 good practice statements.
This course focuses on the science of U=U and how to effectively spread the message in a clear, stigma-free manner.
Developed by the National Institutes of Health, the Centers for Disease Control and Prevention, and the HIV Medicine Association of the Infectious Diseases Society of America Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV—A Working Group of the NIH Office of AIDS Research Advisory Council (OARAC)
Co-authored by CTN+ Investigators Drs. Chelsea Elwood and Mark Yudin, this documents aims to provide guidance for routine antenatal screening of hepatitis C virus in pregnancy to support best practice and optimize antenatal and infectious disease care.
While exclusive formula feeding remains the preferred recommendation for infants born to women living with HIV in high-income countries, a more nuanced approach that may include the option of breastfeeding under certain circumstances is emerging in many resource-rich countries.
The objective of the Canadian HIV Pregnancy Planning Guidelines is to provide clinical information and recommendations for health care providers to assist Canadians affected by HIV with their fertility, preconception, and pregnancy planning decisions.
This course is delivered online by a CATIE health educator, providing instruction through a combination of interactive e-learning units, readings, videos, and discussion board assignments. The course culminates in an online meeting where participants can learn and discuss implications for their daily work.
This course aims to develop in-depth knowledge on the treatment of hepatitis C for frontline service providers. Participants will gain information on the benefits of treatment and an overview of what treatment for hepatitis C typically includes.